| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000236514.1 |
Cytarabine |
Breast invasive carcinoma |
0.004377787 |
Resistant |
| ENSG00000236514.1 |
Cytarabine |
Colon adenocarcinoma |
0.033126975 |
Resistant |
| ENSG00000236514.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.011423702 |
Resistant |
